Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches

Carolina Velasco-Aguirre,1,2,* Francisco Morales,1,2,* Eduardo Gallardo-Toledo,1,2 Simon Guerrero,1,2 Ernest Giralt,3,4 Eyleen Araya,5 Marcelo J Kogan1,2 1Departamento de Química Farmacológica y Toxicológica, Facultad de Ciencias Químicas y Farmac&eacu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Velasco-Aguirre C, Morales F, Gallardo-Toledo E, Guerrero S, Giralt E, Araya E, Kogan MJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/a154a92e7045443282bf05e6a8cfe867
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a154a92e7045443282bf05e6a8cfe867
record_format	dspace
spelling	oai:doaj.org-article:a154a92e7045443282bf05e6a8cfe8672021-12-02T00:31:21ZPeptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches1178-2013https://doaj.org/article/a154a92e7045443282bf05e6a8cfe8672015-08-01T00:00:00Zhttp://www.dovepress.com/peptides-and-proteins-used-to-enhance-gold-nanoparticle-delivery-to-th-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Carolina Velasco-Aguirre,1,2,* Francisco Morales,1,2,* Eduardo Gallardo-Toledo,1,2 Simon Guerrero,1,2 Ernest Giralt,3,4 Eyleen Araya,5 Marcelo J Kogan1,2 1Departamento de Química Farmacológica y Toxicológica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, 2Advanced Center for Chronic Diseases (ACCDiS), Santiago, Chile; 3Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain, 4Department of Organic Chemistry, University of Barcelona, Barcelona, Spain; 5Departamento de Ciencias Químicas, Facultad de Ciencias Exactas, Universidad Andrés Bello, Andrés Bello, Santiago, Chile*These authors contributed equally to this work Abstract: An exciting and emerging field in nanomedicine involves the use of gold nanoparticles (AuNPs) in the preclinical development of new strategies for the treatment and diagnosis of brain-related diseases such as neurodegeneration and cerebral tumors. The treatment of many brain-related disorders with AuNPs, which possess useful physical properties, is limited by the blood–brain barrier (BBB). The BBB highly regulates the substances that can permeate into the brain. Peptides and proteins may represent promising tools to improve the delivery of AuNPs to the central nervous system (CNS). In this review, we summarize the potential applications of AuNPs to CNS disorders, discuss different strategies based on the use of peptides or proteins to improve the delivery of AuNPs to the brain, and examine the intranasal administration route, which bypasses the BBB. We also analyze the potential neurotoxicity of AuNPs and the perspectives and new challenges concerning the use of peptides and proteins to enhance the delivery of AuNPs to the brain. The majority of the work described in this review is in a preclinical stage of experimentation, or in select cases, in clinical trials in humans. We note that the use of AuNPs still requires substantial study before being translated into human applications. However, for further clinical research, the issues related to the potential use of AuNPs must be analyzed.Keywords: blood–brain barrier, central nervous system, transcytosis, drug delivery, EPR effect, biodistributionVelasco-Aguirre CMorales FGallardo-Toledo EGuerrero SGiralt EAraya EKogan MJDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2015, Iss default, Pp 4919-4936 (2015)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Velasco-Aguirre C Morales F Gallardo-Toledo E Guerrero S Giralt E Araya E Kogan MJ Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches
description	Carolina Velasco-Aguirre,1,2,* Francisco Morales,1,2,* Eduardo Gallardo-Toledo,1,2 Simon Guerrero,1,2 Ernest Giralt,3,4 Eyleen Araya,5 Marcelo J Kogan1,2 1Departamento de Química Farmacológica y Toxicológica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, 2Advanced Center for Chronic Diseases (ACCDiS), Santiago, Chile; 3Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain, 4Department of Organic Chemistry, University of Barcelona, Barcelona, Spain; 5Departamento de Ciencias Químicas, Facultad de Ciencias Exactas, Universidad Andrés Bello, Andrés Bello, Santiago, Chile*These authors contributed equally to this work Abstract: An exciting and emerging field in nanomedicine involves the use of gold nanoparticles (AuNPs) in the preclinical development of new strategies for the treatment and diagnosis of brain-related diseases such as neurodegeneration and cerebral tumors. The treatment of many brain-related disorders with AuNPs, which possess useful physical properties, is limited by the blood–brain barrier (BBB). The BBB highly regulates the substances that can permeate into the brain. Peptides and proteins may represent promising tools to improve the delivery of AuNPs to the central nervous system (CNS). In this review, we summarize the potential applications of AuNPs to CNS disorders, discuss different strategies based on the use of peptides or proteins to improve the delivery of AuNPs to the brain, and examine the intranasal administration route, which bypasses the BBB. We also analyze the potential neurotoxicity of AuNPs and the perspectives and new challenges concerning the use of peptides and proteins to enhance the delivery of AuNPs to the brain. The majority of the work described in this review is in a preclinical stage of experimentation, or in select cases, in clinical trials in humans. We note that the use of AuNPs still requires substantial study before being translated into human applications. However, for further clinical research, the issues related to the potential use of AuNPs must be analyzed.Keywords: blood–brain barrier, central nervous system, transcytosis, drug delivery, EPR effect, biodistribution
format	article
author	Velasco-Aguirre C Morales F Gallardo-Toledo E Guerrero S Giralt E Araya E Kogan MJ
author_facet	Velasco-Aguirre C Morales F Gallardo-Toledo E Guerrero S Giralt E Araya E Kogan MJ
author_sort	Velasco-Aguirre C
title	Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches
title_short	Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches
title_full	Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches
title_fullStr	Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches
title_full_unstemmed	Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches
title_sort	peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches
publisher	Dove Medical Press
publishDate	2015
url	https://doaj.org/article/a154a92e7045443282bf05e6a8cfe867
work_keys_str_mv	AT velascoaguirrec peptidesandproteinsusedtoenhancegoldnanoparticledeliverytothebrainpreclinicalapproaches AT moralesf peptidesandproteinsusedtoenhancegoldnanoparticledeliverytothebrainpreclinicalapproaches AT gallardotoledoe peptidesandproteinsusedtoenhancegoldnanoparticledeliverytothebrainpreclinicalapproaches AT guerreros peptidesandproteinsusedtoenhancegoldnanoparticledeliverytothebrainpreclinicalapproaches AT giralte peptidesandproteinsusedtoenhancegoldnanoparticledeliverytothebrainpreclinicalapproaches AT arayae peptidesandproteinsusedtoenhancegoldnanoparticledeliverytothebrainpreclinicalapproaches AT koganmj peptidesandproteinsusedtoenhancegoldnanoparticledeliverytothebrainpreclinicalapproaches
_version_	1718403695179202560

Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches

Ejemplares similares